Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmirtazapine in Chronic Primary Insomnia
NCT00506389Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of esmirtazapine in Chronic Primary Insomnia (3 arms), sponsored by Merck & Co. Primary endpoint: Wake Time After Sleep Onset. Started Jun 2007; status: completed.
02
Drugs
esmirtazapine
03
Conditions
Chronic Primary Insomnia
Beyond the preview
Go deeper on NCT00506389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00506389.